OPKO Health
OPK
$1.57
Share price
-1.87%
Change (1 day)
-35.66%
Change (1 year)
OPKO Health (OPK) - Net assets
Net assets on the balance sheet as of June 2023 : $1.53 B
According to OPKO Health
's latest financial reports the company has $1.53 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
OPKO Health - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $1.56 B | -7.33% |
| 2021-12-31 | $1.68 B | 0.81% |
| 2020-12-31 | $1.67 B | 3.52% |
| 2019-12-31 | $1.61 B | -9.85% |
| 2018-12-31 | $1.79 B | -2.84% |
| 2017-12-31 | $1.84 B | -11.86% |
| 2016-12-31 | $2.09 B | 5.66% |
| 2015-12-31 | $1.97 B | 136.87% |
| 2014-12-31 | $0.83 B | -4.26% |
| 2013-12-31 | $0.87 B | 329.45% |
| 2012-12-31 | $0.20 B | 26.35% |
| 2011-12-31 | $0.16 B | 597.91% |
| 2010-12-31 | $23.05 M | -60.07% |
| 2009-12-31 | $57.72 M | 15979.94% |
| 2008-12-31 | $0.35 M | -97.86% |
| 2007-12-31 | $16.78 M | 107.77% |
| 2006-12-31 | $8.07 M | -7.39% |
| 2005-12-31 | $8.72 M | -11.28% |
| 2004-12-31 | $9.83 M | -4.58% |
| 2003-12-31 | $10.3 M | -35.9% |
| 2002-12-31 | $16.07 M | -38.46% |
| 2001-12-31 | $26.12 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.86 B | 4,515.82% | 🇺🇸 USA |
 Abbott Laboratories ABT | $37.23 B | 2,324.98% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $24.01 B | 1,464.33% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $32.03 B | 1,986.17% | 🇺🇸 USA |
 LabCorp LH | $8.79 B | 472.63% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.41 B | -126.58% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $7.70 B | 402.04% | 🇮🇱 Israel |
 Ardelyx ARDX | $0.12 B | -91.98% | 🇺🇸 USA |